| The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes | Blood | 2009 | 3.2K |
| A gain-of-function mutation of JAK2 in myeloproliferative disorders | New England Journal of Medicine | 2005 | 2.8K |
| Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders | Lancet, The | 2005 | 2.6K |
| Cancer epigenetics: from mechanism to therapy | Cell | 2012 | 1.9K |
| Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome | Science | 1990 | 1.9K |
| The World Health Organization (WHO) classification of the myeloid neoplasms | Blood | 2002 | 1.6K |
| Cellular signaling by fibroblast growth factor receptors | Cytokine and Growth Factor Reviews | 2005 | 1.4K |
| Atherosclerosis: current pathogenesis and therapeutic options | Nature Medicine | 2011 | 1.4K |
| Mutation in TET2 in myeloid cancers | New England Journal of Medicine | 2009 | 1.4K |
| Somatic mutations of calreticulin in myeloproliferative neoplasms | New England Journal of Medicine | 2013 | 1.4K |
| Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 | New England Journal of Medicine | 2013 | 1.3K |
| Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML | New England Journal of Medicine | 2004 | 1.2K |
| Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells | Nature | 2006 | 1.1K |
| JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis | New England Journal of Medicine | 2007 | 996 |
| Targeting the IL-6/JAK/STAT3 signalling axis in cancer | Nature Reviews Clinical Oncology | 2018 | 975 |
| Diagnostic criteria and classification of mastocytosis: a consensus proposal | Leukemia Research | 2001 | 871 |
| MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients | Blood | 2006 | 833 |
| Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms | Leukemia | 2008 | 780 |
| Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia | Nature Reviews Cancer | 2005 | 758 |
| Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel | Blood | 2007 | 715 |
| Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders | Blood | 2005 | 706 |
| miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice | Journal of Experimental Medicine | 2011 | 658 |
| Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow | Blood | 1998 | 648 |
| Inositol phosphatase SHIP1 is a primary target of miR-155 | Proceedings of the National Academy of Sciences of the United States of America | 2009 | 644 |
| Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project | Blood | 2010 | 624 |
